Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Published:2014-01 Issue:9911 Volume:383 Page:31-39
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Fuchs Charles S,Tomasek Jiri,Yong Cho Jae,Dumitru Filip,Passalacqua Rodolfo,Goswami Chanchal,Safran Howard,dos Santos Lucas Vieira,Aprile Giuseppe,Ferry David R,Melichar Bohuslav,Tehfe Mustapha,Topuzov Eldar,Zalcberg John Raymond,Chau Ian,Campbell William,Sivanandan Choondal,Pikiel Joanna,Koshiji Minori,Hsu Yanzhi,Liepa Astra M,Gao Ling,Schwartz Jonathan D,Tabernero Josep

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Chemotherapy for advanced gastric cancer;Wagner;Cochrane Database Syst Rev,2010

3. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model;Jung;Eur J Cancer,2002

4. The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer;Kim;Gut Liver,2009

5. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients;Lieto;Ann Surg Oncol,2008

Cited by 1750 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF signaling: Role in angiogenesis and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

2. The Role of the PTEN Tumor Suppressor Gene and Its Anti-Angiogenic Activity in Melanoma and Other Cancers;Molecules;2024-02-04

3. A robust and validated LC–MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay;Journal of Chromatography B;2024-02

4. Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the MET Gene: Doublet Treatment versus Single Agent Treatment;International Journal of Molecular Sciences;2024-02-01

5. Therapeutic Immunomodulation in Gastric Cancer;Cancers;2024-01-28